Featured Research

from universities, journals, and other organizations

Alzheimer’s Drug Improves Memory Of MS Patients

Date:
November 30, 2004
Source:
American Academy Of Neurology
Summary:
Taking a drug used for Alzheimer’s disease may improve the memory of people with multiple sclerosis (MS), according to a study published in the November 9 issue of Neurology, the scientific journal of the American Academy of Neurology.

St. Paul, Minn. – Taking a drug used for Alzheimer’s disease may improve the memory of people with multiple sclerosis (MS), according to a study published in the November 9 issue of Neurology, the scientific journal of the American Academy of Neurology.

About half of all MS patients experience problems with memory and other cognitive functions. These problems are a leading cause of disability for people with MS. There are currently no drugs to treat this symptom of MS.

The study involved 69 people with MS and mild cognitive problems. Half of the participants took the drug donepezil for 24 weeks and the other half took a placebo. The participants were given tests of memory and other cognitive functions at the beginning and end of the study.

At the end of the study, those taking donepezil improved by an average of 14 percent on the memory test, compared to a 3-percent improvement for those taking the placebo. And 66 percent of those taking the drug felt that their memory had improved, compared to 32 percent of those taking the placebo.

“The possibility that memory and cognitive impairment in MS could benefit from drug treatment is of major importance to patients and their families,” said study author and neurologist Lauren Krupp, MD, of Stony Brook University Hospital in New York. “Any treatment that would enhance their ability to meet the mental challenges of their daily lives would be helpful.”

Krupp said that a larger study should be done to confirm these results.

“MS patients typically take several drugs already, so before any new treatment is added for symptoms, we should have strong evidence that it will truly be beneficial,” she said.

There were no serious side effects from the drug. Those taking donepezil were more likely to have unusual or abnormal dreams than those taking the placebo.

The researchers don’t know how donepezil may work in the brain to help improve memory in people with MS. Donepezil belongs to a class of drugs called acetylcholinesterase inhibitors. In Alzheimer’s disease, the drug blocks the breakdown of acetylcholine.

“MS is not known to result in the reduction of acetylcholine,” Krupp said. “But evidence suggests that there is a decrease in cholinergic activity, likely resulting from the disruption of cholinergic pathways by the demyelination and axonal damage to the nerves that occurs in MS.”

In an accompanying editorial, P. Murali Doraiswamy, MD, of Duke University Medical Center in Durham, NC, noted that the study is good news for patients and highlights a major unmet need. But he cautioned that several long-term questions still needed to be answered. “For example, how long do you use the treatment, and how do you tell if the drug is no longer working? Are the benefits lost once you stop treatment? Are there long-term risks? Is the treatment cost-effective?”

Doraiswamy also noted that other classes of drugs should be tested for potential benefits for the cognitive symptoms of MS. “Hopefully, such studies in the near future will lead to more treatment options for people with MS.”

The study was supported by grants from the National Institutes of Health, the National Institutes for Disability and Rehabilitation Research, the National Multiple Sclerosis Society, and the National Center for Research Resources.

The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, autism and multiple sclerosis.

For more information about the American Academy of Neurology, visit its web site at http://www.aan.com.


Story Source:

The above story is based on materials provided by American Academy Of Neurology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy Of Neurology. "Alzheimer’s Drug Improves Memory Of MS Patients." ScienceDaily. ScienceDaily, 30 November 2004. <www.sciencedaily.com/releases/2004/11/041123114858.htm>.
American Academy Of Neurology. (2004, November 30). Alzheimer’s Drug Improves Memory Of MS Patients. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2004/11/041123114858.htm
American Academy Of Neurology. "Alzheimer’s Drug Improves Memory Of MS Patients." ScienceDaily. www.sciencedaily.com/releases/2004/11/041123114858.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins